149 related articles for article (PubMed ID: 11438649)
1. Self-association of CIITA and its transactivation potential.
Sisk TJ; Roys S; Chang CH
Mol Cell Biol; 2001 Aug; 21(15):4919-28. PubMed ID: 11438649
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cell-specific MHC class II transactivator contains a caspase recruitment domain that confers potent transactivation activity.
Nickerson K; Sisk TJ; Inohara N; Yee CS; Kennell J; Cho MC; Yannie PJ; Nunez G; Chang CH
J Biol Chem; 2001 Jun; 276(22):19089-93. PubMed ID: 11279191
[TBL] [Abstract][Full Text] [Related]
3. CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation.
Hake SB; Masternak K; Kammerbauer C; Janzen C; Reith W; Steimle V
Mol Cell Biol; 2000 Oct; 20(20):7716-25. PubMed ID: 11003667
[TBL] [Abstract][Full Text] [Related]
4. Degradation, Promoter Recruitment and Transactivation Mediated by the Extreme N-Terminus of MHC Class II Transactivator CIITA Isoform III.
Beaulieu YB; Leon Machado JA; Ethier S; Gaudreau L; Steimle V
PLoS One; 2016; 11(2):e0148753. PubMed ID: 26871568
[TBL] [Abstract][Full Text] [Related]
5. The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.
Brown JA; Rogers EM; Boss JM
Nucleic Acids Res; 1998 Sep; 26(18):4128-36. PubMed ID: 9722631
[TBL] [Abstract][Full Text] [Related]
6. The histone acetyltransferase domains of CREB-binding protein (CBP) and p300/CBP-associated factor are not necessary for cooperativity with the class II transactivator.
Harton JA; Zika E; Ting JP
J Biol Chem; 2001 Oct; 276(42):38715-20. PubMed ID: 11514574
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of class II transactivator regulates its interaction ability and transactivation function.
Sisk TJ; Nickerson K; Kwok RP; Chang CH
Int Immunol; 2003 Oct; 15(10):1195-205. PubMed ID: 13679389
[TBL] [Abstract][Full Text] [Related]
8. MHC class II transactivator inhibits IL-4 gene transcription by competing with NF-AT to bind the coactivator CREB binding protein (CBP)/p300.
Sisk TJ; Gourley T; Roys S; Chang CH
J Immunol; 2000 Sep; 165(5):2511-7. PubMed ID: 10946277
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N
J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831
[TBL] [Abstract][Full Text] [Related]
10. GTP binding by class II transactivator: role in nuclear import.
Harton JA; Cressman DE; Chin KC; Der CJ; Ting JP
Science; 1999 Aug; 285(5432):1402-5. PubMed ID: 10464099
[TBL] [Abstract][Full Text] [Related]
11. GTP-dependent recruitment of CIITA to the class II major histocompatibility complex promoter.
Bewry NN; Bolick SC; Wright KL; Harton JA
J Biol Chem; 2007 Sep; 282(36):26178-84. PubMed ID: 17623662
[TBL] [Abstract][Full Text] [Related]
12. Importance of class II transactivator leucine-rich repeats for dominant-negative function and nucleo-cytoplasmic transport.
Camacho-Carvajal MM; Klingler S; Schnappauf F; Hake SB; Steimle V
Int Immunol; 2004 Jan; 16(1):65-75. PubMed ID: 14688062
[TBL] [Abstract][Full Text] [Related]
13. Two distinct domains within CIITA mediate self-association: involvement of the GTP-binding and leucine-rich repeat domains.
Linhoff MW; Harton JA; Cressman DE; Martin BK; Ting JP
Mol Cell Biol; 2001 May; 21(9):3001-11. PubMed ID: 11287606
[TBL] [Abstract][Full Text] [Related]
14. A 36-amino-acid region of CIITA is an effective inhibitor of CBP: novel mechanism of gamma interferon-mediated suppression of collagen alpha(2)(I) and other promoters.
Zhu XS; Ting JP
Mol Cell Biol; 2001 Oct; 21(20):7078-88. PubMed ID: 11564890
[TBL] [Abstract][Full Text] [Related]
15. MHC class II transactivator represses human IL-4 gene transcription by interruption of promoter binding with CBP/p300, STAT6 and NFAT1 via histone hypoacetylation.
Zhou X; Jiang Y; Lu L; Ding Q; Jiao Z; Zhou Y; Xin L; Chou KY
Immunology; 2007 Dec; 122(4):476-85. PubMed ID: 17645498
[TBL] [Abstract][Full Text] [Related]
16. Multiple interactions between BRG1 and MHC class II promoter binding proteins.
Mudhasani R; Fontes JD
Mol Immunol; 2005 Apr; 42(6):673-82. PubMed ID: 15781111
[TBL] [Abstract][Full Text] [Related]
17. Combinations of dominant-negative class II transactivator, p300 or CDK9 proteins block the expression of MHC II genes.
Kanazawa S; Peterlin BM
Int Immunol; 2001 Jul; 13(7):951-8. PubMed ID: 11431425
[TBL] [Abstract][Full Text] [Related]
18. Association of the 19S proteasomal ATPases with the ATPase-binding domain of CIITA is essential for CIITA stability and MHC class II expression.
Bhat KP; Truax AD; Brooks JK; Greer SF
Immunol Cell Biol; 2010; 88(8):807-16. PubMed ID: 20351748
[TBL] [Abstract][Full Text] [Related]
19. Class II major histocompatibility complex transactivator (CIITA) inhibits matrix metalloproteinase-9 gene expression.
Nozell S; Ma Z; Wilson C; Shah R; Benveniste EN
J Biol Chem; 2004 Sep; 279(37):38577-89. PubMed ID: 15247301
[TBL] [Abstract][Full Text] [Related]
20. The GTP-binding domain of class II transactivator regulates its nuclear export.
Raval A; Weissman JD; Howcroft TK; Singer DS
J Immunol; 2003 Jan; 170(2):922-30. PubMed ID: 12517958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
